The Dell Medical School and the University of Texas at Austin would like to nominate Dr. Kyaw Aung, Assistant Professor of Oncology and the Livestrong Cancer Institutes (LCI) for a 2021 CPRIT Early Clinical Investigator Award. Dr. Kyaw Aung was appointed to his current position in February 2019 to lead pancreatic cancer clinical and translational research under the mentorship of Dr. S. Gail Eckhardt, Professor and Chair of the Department of Oncology and LCI director, and Dr. William Matsui, Professor of Oncology, Associate Chair of Research, and LCI deputy director. We confirm that he meets all the eligibility criteria for this award. He is an expert gastrointestinal medical oncologist with ...
Read More
The Dell Medical School and the University of Texas at Austin would like to nominate Dr. Kyaw Aung, Assistant Professor of Oncology and the Livestrong Cancer Institutes (LCI) for a 2021 CPRIT Early Clinical Investigator Award. Dr. Kyaw Aung was appointed to his current position in February 2019 to lead pancreatic cancer clinical and translational research under the mentorship of Dr. S. Gail Eckhardt, Professor and Chair of the Department of Oncology and LCI director, and Dr. William Matsui, Professor of Oncology, Associate Chair of Research, and LCI deputy director. We confirm that he meets all the eligibility criteria for this award. He is an expert gastrointestinal medical oncologist with specialist skills in early phase drug development and an outstanding track record in clinical and translational cancer research. His career mission is to build a comprehensive pancreatic cancer research program that bidirectionally incorporates the laboratory and clinic through a truly multidisciplinary approach with clinicians, laboratory scientists, and industry partners. This will be accomplished through innovative hypothesis-driven clinical trials complemented by comprehensive correlative biomarker analyses that further inform laboratory preclinical studies and vice versa. This approach will allow him to systematically study pancreatic cancer biology in the context of drug response and resistance and ultimately lead to personalized and immunology-based therapeutics for pancreatic cancer patients to impact survival. We sincerely believe that Dr. Kyaw Aung will truly benefit from CPRIT Early Clinical Investigator Award as this will give him the opportunity to gain further critical skills and advance his expertise in preclinical and laboratory research enabling him to establish an independent clinician scientist career. We strongly believe that he has the potential to become a world leading pancreatic cancer researcher and is truly worthy of this award.
Read Less
|
